Related Experiment Video
Updated: Aug 15, 2026

Understanding the Impact of Temperate Bacteriophages on Their Lysogens Through Transcriptomics
Published on: January 5, 2024
Harnessing phages in the age of antibiotic resistance: immunological perspectives
Tasnime A Abdo Ahmad1, Dina Kabbara1, Zahraa Shokor1
1Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
Abstract:
The rapid rise of antimicrobial resistance (AMR) has renewed interest in bacteriophages as precision antibacterial agents that can selectively target pathogenic bacteria while limiting disruption of commensal microbiota. However, therapeutic phages are not immunologically inert. Phage particles, phage-derived nucleic acids, bacterial lysis products, and manufacturing impurities can interact with innate and adaptive immune pathways, influencing phage pharmacokinetics, tissue persistence, inflammatory responses, and treatment durability. Innate mechanisms such as complement activation, phagocyte uptake, pattern-recognition receptor signaling, and neutrophil-mediated antibacterial responses may either restrict phage bioavailability or support bacterial clearance. Adaptive immune responses, particularly anti-phage antibodies and serum neutralization, may become relevant during repeated or systemic administration, although available clinical evidence indicates that antibody development does not uniformly predict treatment failure. This review integrates mechanistic, translational, and clinical evidence on phage-immune interactions, distinguishing direct immune recognition of phage components from indirect immune activation mediated by bacteria and bacterial products. We also discuss immune-aware strategies, including phage selection, formulation, route optimization, product-quality control, and immune monitoring, to improve the development of phage therapies for multidrug-resistant bacterial infections.
Insights
Antimicrobial resistance (AMR) drives phage therapy interest. Phages interact with the immune system, affecting treatment efficacy. Immune-aware strategies are crucial for successful phage therapy against resistant infections.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- The rise of antimicrobial resistance (AMR) necessitates novel therapeutic strategies.
- Bacteriophages (phages) are explored as precision antibacterial agents due to their specificity.
- Phages can interact with host immune pathways, impacting their therapeutic potential.
Purpose of the Study:
- To review the complex interactions between bacteriophages and the host immune system.
- To distinguish direct immune recognition of phage components from indirect immune activation.
- To discuss immune-aware strategies for optimizing phage therapy development.
Main Methods:
- Integration of mechanistic, translational, and clinical evidence.
- Analysis of innate immune mechanisms (complement, phagocytes, PRRs, neutrophils).
- Evaluation of adaptive immune responses (antibodies, neutralization).
Main Results:
- Phage components, nucleic acids, and impurities can trigger innate and adaptive immunity.
- Immune responses influence phage pharmacokinetics, persistence, and inflammatory reactions.
- Anti-phage antibodies do not consistently predict treatment failure in clinical settings.
Conclusions:
- Phage-immune interactions are critical determinants of therapeutic outcomes.
- Understanding these interactions is key to developing effective phage therapies.
- Immune-aware strategies are essential for advancing phage therapy for multidrug-resistant infections.
Related Concept Videos
Bacteriophages of the Human Virome
Antibiotic Selection
Transduction
Lytic Cycle of Bacteriophages
Microorganisms in Medicine and Therapeutics
Clinical Significance of Antibiotic Resistance

